Altered cortical maturation in adolescent cannabis users with and without schizophrenia

Schizophrenia Research

Volumn 162, Issue 1-3, 2015, Pages 143-152

  Epstein, Katherine A ^a   Kumra, Sanjiv ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cortical; Critical period; Endocannabinoid; Gray matter; Schizophrenia; Structural imaging

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN MATURATION; CANNABIS ADDICTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DRUG ABUSE PATTERN; FEMALE; GRAY MATTER; HUMAN; INFERIOR PARIETAL LOBULE; LEFT HEMISPHERE; MALE; MENTAL PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARS OPERCULARIS; PARS TRIANGULARIS; PRIORITY JOURNAL; RIGHT HEMISPHERE; SCHIZOPHRENIA; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; SUPRAMARGINAL GYRUS; BRAIN CORTEX; COMPLICATION; COMPUTER PROGRAM; DRUG EFFECTS; FOLLOW UP; GROWTH, DEVELOPMENT AND AGING; IMAGE PROCESSING; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; ONSET AGE; ORGAN SIZE; PATHOLOGY; PSYCHOSIS; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; AGE OF ONSET; CEREBRAL CORTEX; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; MULTIVARIATE ANALYSIS; ORGAN SIZE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SOFTWARE; YOUNG ADULT;

EID: 84923225360     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.11.029     Document Type: Article

References (60)

1. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39(7):784-788.
2. Andreasen N.C., Pressler M., Nopoulos P., Miller D., Ho B.C. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry 2010, 67(3):255-262.
3. Arango C., Rapado-Castro M., Reig S., Castro-Fornieles J., Gonzalez-Pinto A., Otero S., Baeza I., Moreno C., Graell M., Janssen J., Parellada M., Moreno D., Bargallo N., Desco M. Progressive brain changes in children and adolescents with first-episode psychosis. Arch. Gen. Psychiatry. 2012, 69(1):16-26.
4. Battistella G., Fornari E., Annoni J.M., Chtioui H., Dao K., Fabritius M., Favrat B., Mall J.F., Maeder P., Giroud C. Long-term effects of cannabis on brain structure. Neuropsychopharmacology. 2014, 39(9):2041-2048.
5. Bisogno T., Di Marzo V. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders. Pharmacol. Res. 2007, 56(5):428-442.
6. Bossong M.G., Niesink R.J. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog. Neurobiol. 2010, 92(3):370-385.
7. Buchanan R.W., Francis A., Arango C., Miller K., Lefkowitz D.M., McMahon R.P., Barta P.E., Pearlson G.D. Morphometric assessment of the heteromodal association cortex in schizophrenia. Am. J. Psychiatry 2004, 161(2):322-331.
8. Burgaleta M., Johnson W., Waber D.P., Colom R., Karama S. Cognitive ability changes and dynamics of cortical thickness development in healthy children and adolescents. Neuroimage 2014, 84:810-819.
9. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8(3):470-484.
10. Cousijn J., Wiers R.W., Ridderinkhof K.R., van den Brink W., Veltman D.J., Goudriaan A.E. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 2012, 59(4):3845-3851.
11. Crews F., He J., Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol. Biochem. Behav. 2007, 86(2):189-199.
12. Culbertson W.C., Zillmer E.A. Tower of London 2005, Psychological Assessment Resources, Lutz, FL. 2nd ed.
13. Delis D.C., Kaplan E., Kramer J.H. Delis-Kaplan Executive Function System (D-KEFS) 2001, The Psychological Corporation, San Antonio, TX.
14. DeRosse P., Kaplan A., Burdick K.E., Lencz T., Malhotra A.K. Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr. Res. 2010, 120(1-3):95-100.
15. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., Buckner R.L., Dale A.M., Maguire R.P., Hyman B.T., Albert M.S., Killiany R.J. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31(3):968-980.
16. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 1991, 148(2):224-230.
17. Dorph-Petersen K.A., Pierri J.N., Perel J.M., Sun Z., Sampson A.R., Lewis D.A. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 2005, 30(9):1649-1661.
18. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
19. Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., Nugent T.F., Herman D.H., Clasen L.S., Toga A.W., Rapoport J.L., Thompson P.M. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(21):8174-8179.
20. Harkany T., Mackie K., Doherty P. Wiring and firing neuronal networks: endocannabinoids take center stage. Curr. Opin. Neurobiol. 2008, 18(3):338-345.
21. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68(2):128-137.
22. Hollingshead A.B., Redlich F.C. Social class and mental illness: a community study. 1958. Am. J. Public Health 2007, 97(10):1756-1757.
23. Huttenlocher P.R. Morphometric study of human cerebral cortex development. Neuropsychologia. 1990, 28(6):517-527.
24. James A., Hough M., James S., Winmill L., Burge L., Nijhawan S., Matthews P.M., Zarei M. Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr. Res. 2011, 128(1-3):91-97.
25. James A., James C., Thwaites T. The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Res. 2013, 214(3):181-189.
26. James A.C. Prescribing antipsychotics for children and adolescents. Adv. Psychiatr. Treat. 2010, 16:63-75.
27. Jarvis K., DelBello M.P., Mills N., Elman I., Strakowski S.M., Adler C.M. Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J. Child Adolesc. Psychopharmacol. 2008, 18(6):557-563.
28. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2010, 36(6):1115-1130.
29. Kumra S., Robinson P., Tambyraja R., Jensen D., Schimunek C., Houri A., Reis T., Lim K. Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J. Am. Acad. Child Adolesc. Psychiatry 2012, 51(2):171-180.
30. Lachar D., Randle S.L., Harper R.A., Scott-Gurnell K.C., Lewis K.R., Santos C.W., Saunders A.E., Pearson D.A., Loveland K.A., Morgan S.T. The Brief Psychiatric Rating Scale for Children (BPRS-C): validity and reliability of an anchored version. J. Am. Acad. Child Adolesc. Psychiatry 2001, 40(3):333-340.
31. Lazeron R.H., Rombouts S.A., Machielsen W.C., Scheltens P., Witter M.P., Uylings H.B., Barkhof F. Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging. AJNR Am. J. Neuroradiol. 2000, 21(8):1407-1414.
32. Lisdahl K.M., Gilbart E.R., Wright N.E., Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry. 2013, 4:53.
33. Liu C.H., Heynen A.J., Shuler M.G., Bear M.F. Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex. Neuron. 2008, 58(3):340-345.
34. Lopez-Larson M.P., Bogorodzki P., Rogowska J., McGlade E., King J.B., Terry J., Yurgelun-Todd D. Altered prefrontal and insular cortical thickness in adolescent marijuana users. Behav. Brain Res. 2011, 220(1):164-172.
35. Luciana M., Collins P.F., Olson E.A., Schissel A.M. Tower of London performance in healthy adolescents: the development of planning skills and associations with self-reported inattention and impulsivity. Dev. Neuropsychol. 2009, 34(4):461-475.
36. Mata I., Perez-Iglesias R., Roiz-Santianez R., Tordesillas-Gutierrez D., Pazos A., Gutierrez A., Vazquez-Barquero J.L., Crespo-Facorro B. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res. 2010, 1317:297-304.
37. Medina K.L., McQueeny T., Nagel B.J., Hanson K.L., Yang T.T., Tapert S.F. Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict. Biol. 2009, 14(4):457-468.
38. Medina K.L., Nagel B.J., Tapert S.F. Abnormal cerebellar morphometry in abstinent adolescent marijuana users. Psychiatry Res. 2010, 182(2):152-159.
39. Medina K.L., Schweinsburg A.D., Cohen-Zion M., Nagel B.J., Tapert S.F. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry. Neurotoxicol. Teratol. 2007, 29(1):141-152.
40. Mesulam M.M. Principles of behavioral and cognitive neurology 2000, Oxford University Press, Oxford, New York.
41. Overall J., Gorham D. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
42. Paus T. Growth of white matter in the adolescent brain: myelin or axon?. Brain Cogn. 2010, 72(1):26-35.
43. Pope H.G., Gruber A.J., Hudson J.I., Cohane G., Huestis M.A., Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend. 2003, 69(3):303-310.
44. Rabin R.A., Zakzanis K.K., George T.P. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophr. Res. 2011, 128(1-3):111-116.
45. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., Kahn R. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry 2008, 165(4):490-496.
46. Rais M., van Haren N.E., Cahn W., Schnack H.G., Lepage C., Collins L., Evans A.C., Hulshoff Pol H.E., Kahn R.S. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur. Neuropsychopharmacol. 2010, 20(12):855-865.
47. Rodriguez-Sanchez J.M., Ayesa-Arriola R., Mata I., Moreno-Calle T., Perez-Iglesias R., Gonzalez-Blanch C., Perianez J.A., Vazquez-Barquero J.L., Crespo-Facorro B. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr. Res. 2010, 124(1-3):142-151.
48. Ross C.A., Pearlson G.D. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci. 1996, 19(5):171-176.
49. Sarne Y., Mechoulam R. Cannabinoids: between neuroprotection and neurotoxicity. Curr. Drug Targets CNS Neurol. Disord. 2005, 4(6):677-684.
50. Shallice T. Specific impairments of planning. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1982, 298(1089):199-209.
51. Sobell L.C., Sobell M.B. Timeline followback: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods 1992, 41-72. Humana Press, New Jersey. R.Z. Litten, J. Allen (Eds.).
52. Sowell E.R., Delis D., Stiles J., Jernigan T.L. Improved memory functioning and frontal lobe maturation between childhood and adolescence: a structural MRI study. J. Int. Neuropsychol. Soc. 2001, 7(3):312-322.
53. Sporn A.L., Greenstein D.K., Gogtay N., Jeffries N.O., Lenane M., Gochman P., Clasen L.S., Blumenthal J., Giedd J.N., Rapoport J.L. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am. J. Psychiatry 2003, 160(12):2181-2189.
54. Squeglia L.M., Jacobus J., Tapert S.F. The influence of substance use on adolescent brain development. Clin. EEG Neurosci. 2009, 40(1):31-38.
55. Substance Abuse and Mental Health Services Administration Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
56. Tae W.S., Kim S.S., Lee K.U., Nam E.C., Kim K.W. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology 2008, 50(7):569-581.
57. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., Toga A.W., Rapoport J.L. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(20):11650-11655.
58. Verrico C.D., Gu H., Peterson M.L., Sampson A.R., Lewis D.A. Repeated Delta9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am. J. Psychiatry. 2014, 171(4):416-425.
59. Wilkinson G. Wide Range Achievement Test, 3rd Edition (WRAT-3) Manual 1993, Wide Range, Inc., Wilmington, DE.
60. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., Conus P., Takagi M.J., Fornito A., Wood S.J., McGorry P.D., Pantelis C. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr. Bull. 2012, 38(2):316-330.